Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19

June 08, 2020 01:09:16
Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19
MitoAction Expert Series
Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19

Jun 08 2020 | 01:09:16

/

Show Notes

Join MitoAction and Dr. Richard Frye to discuss the distinction between primary and secondary mitochondrial diagnosis. Some talking points will include:

  • Primary mitochondrial disease (PMD) is ideally diagnosed by a known or indisputably pathogenic mitochondrial or nuclear DNA mutation.
  • Secondary mitochondrial dysfunction (SMD) can be caused by genes encoding either function nor production of the oxphos proteins and accompanies many heriditary non-mitochondrial diseases.
  • Secondary mitochondrial dysfunction (SMD) can also be caused by enviornmental factors.
  • In the absence of the ability to diagnose a primary mitochondrial disease (PMD), mitochondrial dysfunction can be effectively treated with standard treatments for PMD.
  • When the etiology of mitochondrial dysfunction is unknown, re-evaluation for genetic and other causes should be revisited on a regular basis.

About The Speaker:

Dr. Richard Frye is a pediatric neurologist and Chief of the Division of Neurodevelopmental Disorders at Phoenix Children’s Hospital.  He received his MD/PhD from Georgetown University in 1998. He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston University. He holds board certifications in Pediatrics, and in Neurology with Special Competence in Child Neurology. Dr. Frye is a national leader in autism research. He has authored over 100 peer-reviewed publications and book chapters, and serves on several editorial boards of scientific and medical journals.

Other Episodes

Episode 0

June 08, 2020 00:57:14
Episode Cover

Q&A - Impacts of COVID-19 on FAOD's - Dr. Jerry Vockley - 4/7/20

Join MitoAction and Dr. Jerry Vockley from UPMC Children’s Hospital of Pittsburgh for a Q & A to discuss your questions and concerns about...

Listen

Episode 1

September 15, 2020 01:02:06
Episode Cover

Mito Community Call with Kyle of the Two Disabled Dudes

Join MitoAction and featured guest Kyle Bryant of the Two Disabled Dudes for a community call to encourage and inspire you as we kick...

Listen

Episode

March 12, 2025 01:02:47
Episode Cover

Expert Series: Ceramides: The Unmasked Drivers of VLCADD-Induced Heart Failure

Despite advances in newborn screening and treatment of fatty acid oxidation disorders, patients with very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD) continue to suffer from heart...

Listen